human
rhinovirus
hrv
common
caus
respiratori
viru
infect
immunocompet
immunocompromis
although
well
document
case
suggest
possibl
role
hrv
sever
earlier
cohort
studi
conclus
demonstr
abil
hrv
caus
lower
respiratori
tract
diseas
part
presenc
copathogen
well
lack
sensit
molecular
diagnost
widespread
adopt
multiplex
molecular
detect
platform
hrv
rna
detect
frequent
bronchoalveolar
lavag
bal
fluid
immunocompromis
patient
undergo
evalu
pulmonari
howev
signific
hrv
rna
detect
lower
respiratori
tract
remain
poorli
defin
recent
larg
prospect
studi
detect
hrv
upper
respiratori
tract
hematopoiet
cell
transplant
hct
candid
associ
poor
outcom
anoth
studi
also
suggest
poor
outcom
immunocompromis
patient
hrv
infect
compar
infect
lower
respiratori
tract
infect
lri
recent
studi
communityacquir
pneumonia
immunocompet
patient
identifi
hrv
common
pathogen
use
molecular
diagnost
hrv
also
key
pathogen
immunocompromis
patient
origin
diagnos
idiopath
pneumonia
syndrom
detect
lower
respiratori
tract
associ
particularli
poor
overal
data
suggest
hrv
may
clinic
signific
pathogen
potenti
caus
seriou
pulmonari
diseas
purpos
studi
determin
signific
detect
hrv
rna
bal
fluid
hct
recipi
retrospect
studi
includ
patient
transplant
fred
hutchinson
cancer
research
center
fhcrc
virologicallyconfirm
hrv
infect
follow
hct
univers
washington
virolog
individu
first
episod
hrv
infect
analyz
hrv
upper
respiratori
tract
infect
uri
defin
hrv
detect
nasopharyng
sampl
lri
defin
hrv
detect
bal
lung
biopsi
sampl
patient
demograph
data
transplant
inform
closest
hrv
infect
retriev
fhcrc
databas
data
relat
clinic
cours
hrv
infect
collect
medic
chart
review
compar
cohort
patient
lri
caus
respiratori
syncyti
viru
rsv
parainfluenza
viru
piv
influenza
viru
includ
first
episod
lri
virus
select
case
overlap
infect
virus
exclud
analys
studi
approv
institut
review
board
fhcrc
nasopharyng
sampl
collect
hct
recipi
uri
symptom
bal
sampl
obtain
patient
lower
respiratori
tract
symptom
radiograph
abnorm
hrv
detect
perform
convent
cultur
andor
revers
transcriptionpolymeras
chain
reaction
rtpcr
assay
respiratori
sampl
cultur
perform
use
differ
cultur
system
rhesu
monkey
kidney
cell
rmk
adenocarcinom
human
alveolar
basal
epitheli
cell
human
foreskin
fibroblast
hff
bal
sampl
incub
day
addit
day
hff
cultur
rtpcr
detect
hrv
use
routin
sinc
center
rsv
piv
influenza
viru
detect
convent
cultur
direct
fluoresc
antibodi
test
andor
pcr
viral
load
hrv
roughli
estim
pcr
cycl
threshold
ct
valu
sampl
provid
initi
diagnosi
hrv
biopsi
autopsi
sampl
inocul
differ
cell
line
also
test
hrv
use
rtpcr
autopsi
sampl
curl
frozen
specimen
side
lung
separ
test
hrv
use
rtpcr
patient
demograph
characterist
summar
compar
uri
lri
among
lri
differ
virus
hrv
rsv
piv
influenza
viru
use
chisquar
fisher
exact
test
categor
variabl
wilcoxon
rank
sum
test
continu
variabl
appropri
probabl
overal
surviv
estim
use
kaplanmei
method
probabl
mortal
hrv
uri
estim
cumul
incid
curv
treat
progress
lri
compet
risk
probabl
mortal
respiratori
failur
estim
cumul
incid
curv
treat
death
due
caus
compet
risk
logrank
test
use
compar
hazard
timetoev
outcom
among
patient
characterist
cox
proport
hazard
model
use
evalu
unadjust
uhr
adjust
hazard
ratio
ahr
risk
factor
overal
mortal
respiratori
mortal
variabl
univari
model
candid
multivari
model
twosid
p
valu
consid
statist
signific
statist
analys
perform
use
sa
window
patient
diagnos
hrv
infect
uri
alon
lri
respect
characterist
group
shown
tabl
hrv
case
diagnos
reflect
initi
routin
use
pcr
detect
hrv
median
time
hrv
uri
lri
follow
hct
day
rang
day
day
rang
day
respect
approxim
half
patient
hrv
lri
copathogen
diagnosi
aspergillu
includ
case
posit
galactomannan
alon
pseudomona
aeruginosa
consid
nonvir
copathogen
rsv
piv
adenoviru
viral
copathogen
patient
die
within
day
onset
lri
fortyon
patient
die
pulmonari
failur
die
organ
dysfunct
diseas
relaps
acut
graft
versu
host
diseas
gvhd
respect
probabl
overal
mortal
day
follow
hrv
diagnosi
patient
uri
lri
shown
figur
uri
lri
p
probabl
surviv
hrv
lri
patient
without
copathogen
respect
figur
multivari
analysi
risk
factor
overal
mortal
low
monocyt
count
oxygen
requir
diagnosi
steroid
dose
greater
mgkgday
diagnosi
significantli
associ
higher
mortal
analysi
risk
factor
mortal
respiratori
failur
low
monocyt
count
diagnosi
steroid
use
mgkgday
diagnosi
signific
factor
multivari
model
tabl
steroid
use
diagnosi
also
significantli
import
factor
overal
mortal
hr
confid
interv
ci
mortal
respiratori
failur
hr
ci
onlin
supplementari
tabl
allogen
transplant
reach
statist
signific
overal
mortal
hr
ci
mortal
respiratori
failur
hr
ci
examin
homogen
cohort
analyz
cohort
restrict
case
allogen
transplant
hrv
infect
within
year
hct
tabl
oxygen
requir
diagnosi
steroid
dose
greater
mgkgday
diagnosi
import
factor
mortal
tabl
hrv
pcr
ct
valu
bal
sampl
obtain
diagnosi
significantli
associ
mortal
hrv
lri
tabl
case
sequenti
bal
within
day
follow
diagnosi
lri
fourteen
patient
decreas
viral
load
die
remain
patient
stabl
increas
viral
load
six
die
patient
sequenti
nasopharyng
sampl
decreas
increas
viral
load
respect
group
patient
die
investig
whether
hrv
could
potenti
respons
lower
respiratori
tract
diseas
subsequ
death
examin
biopsi
andor
autopsi
sampl
hrv
use
convent
cultur
rtpcr
assay
biopsi
perform
lri
diagnosi
diagnosi
respect
hrv
posit
rtpcr
respect
hrv
posit
cultur
among
patient
hrv
lri
die
within
day
onset
hrv
lri
among
patient
underw
autopsi
median
day
lri
diagnosi
autopsi
day
rang
day
hrv
detect
sampl
rtpcr
sampl
obtain
right
left
lung
posit
posit
case
sampl
posit
cultur
compar
mortal
hrv
lri
lri
caus
rsv
piv
influenza
viru
patient
characterist
shown
tabl
observ
differ
among
variou
viru
cohort
regard
time
onset
transplant
cell
sourc
oxygen
requir
diagnosi
overal
surviv
day
among
group
without
copathogen
similar
figur
sinc
oxygen
requir
diagnosi
import
risk
factor
mortal
reflect
degre
lung
injuri
analyz
surviv
oxygen
requir
shown
figur
group
patient
respiratori
viral
lri
compar
overal
surviv
figur
figur
confirm
mortal
hrv
lri
similar
rsv
piv
influenza
viru
perform
multivari
analysi
among
total
patient
tabl
adjust
model
mortal
hrv
lri
remain
similar
lri
respiratori
virus
tabl
studi
herein
show
patient
hrv
detect
lower
respiratori
tract
similar
outcom
patient
lri
due
known
pathogen
virus
rsv
piv
influenza
viru
even
exclud
potenti
bacteri
fungal
viral
copathogen
although
detect
hrv
rna
rtpcr
proof
ongo
viral
replic
also
abl
detect
replic
viru
lung
tissu
subset
patient
fatal
outcom
thu
demonstr
virus
viabl
potenti
respons
pulmonari
diseas
patient
prove
pathogendiseas
associ
pathogen
difficult
especi
molecular
era
difficult
koch
postul
assess
direct
viral
injuri
easili
appli
despit
detect
viral
nucleic
acid
employ
multipl
strategi
examin
plausibl
hrv
signific
pathogen
includ
comparison
mortal
patient
hrv
detect
upper
lower
respiratori
tract
ii
comparison
patient
without
copathogen
outcom
hrv
lri
iii
evalu
factor
associ
death
follow
hrv
detect
bal
sampl
iv
comparison
mortal
respiratori
virus
wellestablish
pathogen
v
tissu
detect
viru
primari
comparison
patient
hrv
uri
hrv
detect
bal
figur
comparison
mortal
uri
lri
alon
conclus
evid
caus
effect
hrv
lri
two
curv
significantli
differ
addit
look
remark
similar
curv
previous
document
respiratori
virus
piv
hct
second
fact
mortal
patient
without
copathogen
similar
could
suggest
hrv
caus
lri
otherwis
one
would
expect
outcom
improv
patient
without
copathogen
next
factor
associ
mortal
follow
hrv
bal
posit
similar
respiratori
virus
rsv
piv
hmpv
influenza
virus
report
group
includ
oxygen
use
cytopenia
highdos
corti
costeroid
use
tabl
import
analysi
comparison
outcom
hrv
lri
wellestablish
viral
pneumonia
use
previous
describ
analyz
overal
mortal
multivari
cox
model
adjust
key
factor
associ
poor
outcom
differ
mortal
lri
hrv
virus
even
adjust
sever
import
factor
presenc
copathogen
oxygen
use
time
diagnosi
tabl
figur
provid
strong
evid
hrv
detect
bal
inde
clinic
signific
find
although
cox
model
adjust
oxygen
use
perform
subset
analysi
patient
present
without
oxygen
use
figur
group
like
minim
acut
lung
injuri
time
diagnosi
subsequ
outcom
patient
like
associ
viral
insult
rather
inflammatori
chang
associ
acut
lung
injuri
although
mortal
expect
lower
group
mortal
rate
approach
month
diagnosi
document
indic
import
neg
impact
surviv
importantli
appar
differ
lri
outcom
hrv
rsv
piv
influenza
viru
also
examin
virolog
factor
evalu
role
hrv
lung
diseas
tissu
document
pathogen
consid
key
factor
support
pathogen
role
infecti
although
limit
small
number
tissu
sampl
lung
biopsi
autopsi
cohort
abl
cultur
hrv
lung
biopsi
patient
cultur
perform
remark
result
cultur
system
optim
hrv
recoveri
gener
improv
incub
lower
temperatur
method
roller
flask
use
previou
paper
suggest
high
viral
load
may
present
sinc
viral
cultur
posit
biopsi
materi
gener
consid
indic
invas
viral
diseas
respiratori
virus
cytomegaloviru
cmv
consid
find
highli
signific
also
detect
hrv
rna
pcr
archiv
frozen
tissu
lung
biopsi
autopsi
sampl
hrv
pcr
ct
valu
bal
sampl
provid
rough
estim
hrv
viral
load
associ
mortal
cohort
tabl
lack
associ
rule
pathogen
role
hrv
sinc
studi
wellestablish
pathogen
cmv
rsv
piv
also
fail
demonstr
associ
viral
load
bal
methodolog
issu
may
respons
result
includ
inabl
account
bal
dilut
potenti
differenti
amplif
effici
differ
hrv
addit
studi
need
conclus
studi
role
viral
load
bal
hrv
virus
studi
herein
strength
limit
examin
larg
number
case
hrv
rna
posit
bal
compar
case
viral
lower
respiratori
diseas
allow
us
perform
appropri
statist
analys
care
account
copathogen
stage
acut
lung
injuri
studi
restrict
specif
transplant
type
time
period
hct
howev
subgroup
analysi
recent
allogen
transplant
recipi
show
similar
result
due
lack
specif
inform
sever
gvhd
case
associ
mortal
hrv
lri
gvhd
remain
unclear
although
use
steroid
dose
surrog
marker
gvhd
sever
larg
unbias
approach
evalu
patient
pulmonari
infiltr
bronchoscopi
bal
avail
lung
tissu
addit
strength
accord
previou
report
approxim
hrv
uri
case
bal
sampl
asymptomat
hct
recipi
includ
hrv
lri
therefor
think
asymptomat
lower
respiratori
tract
infect
minor
factor
present
studi
limit
includ
lack
tissu
immunohistochem
studi
lack
direct
viral
quantit
well
inabl
adequ
cultur
hrv
autopsi
biopsi
specimen
current
avail
antibodi
hrv
identifi
hrv
serotyp
tissu
sampl
could
perform
immunohistochemistri
confirm
tissu
detect
hrv
furthermor
acknowledg
certain
hrv
strain
particularli
hrvc
virus
may
identifi
earlier
studi
would
unlik
success
cultiv
thu
infect
hrvc
might
underrepres
patient
prior
conclus
provid
evid
hrv
seriou
pathogen
lower
respiratori
tract
hct
recipi
conclus
support
similar
outcom
patient
hrv
bal
compar
wellestablish
respiratori
pathogen
rsv
influenza
viru
presenc
hrv
lung
tissu
data
also
consist
recent
literatur
hrv
clinic
set
support
potenti
causal
role
seriou
clinic
agre
earlier
studi
hct
recipi
carri
prior
use
molecular
diagnost
howev
data
support
pathogen
role
hrv
ultim
proof
could
best
provid
random
placebocontrol
trial
data
provid
rational
rapid
develop
clinic
evalu
new
therapeut
